Jaguar Health, Inc.
JAGX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $11,689 | $9,761 | $11,956 | $4,335 |
| % Growth | 19.8% | -18.4% | 175.8% | – |
| Cost of Goods Sold | $1,955 | $2,037 | $2,019 | $2,333 |
| Gross Profit | $9,734 | $7,724 | $9,937 | $2,002 |
| % Margin | 83.3% | 79.1% | 83.1% | 46.2% |
| R&D Expenses | $16,542 | $18,596 | $17,647 | $15,079 |
| G&A Expenses | $16,331 | $16,588 | $17,868 | $17,103 |
| SG&A Expenses | $24,023 | $23,048 | $26,705 | $25,997 |
| Sales & Mktg Exp. | $7,692 | $6,460 | $8,837 | $8,894 |
| Other Operating Expenses | $0 | $371 | $0 | $1,634 |
| Operating Expenses | $40,565 | $42,015 | $44,352 | $42,710 |
| Operating Income | -$30,831 | -$34,291 | -$34,415 | -$40,708 |
| % Margin | -263.8% | -351.3% | -287.8% | -939.1% |
| Other Income/Exp. Net | -$8,420 | -$7,610 | -$13,980 | -$11,892 |
| Pre-Tax Income | -$39,251 | -$41,901 | -$48,395 | -$52,600 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$38,492 | -$41,300 | -$47,454 | -$52,595 |
| % Margin | -329.3% | -423.1% | -396.9% | -1,213.3% |
| EPS | -130.69 | -2,685 | -4,070,250 | -11,370,375 |
| % Growth | 95.1% | 99.9% | 64.2% | – |
| EPS Diluted | -130.69 | -2,685 | -4,070,250 | -11,370,375 |
| Weighted Avg Shares Out | 295 | 15 | 0 | 0 |
| Weighted Avg Shares Out Dil | 295 | 15 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $8,421 |
| Interest Expense | $231 | $6,382 | $12,723 | $8,421 |
| Depreciation & Amortization | $2,358 | $1,160 | $2,292 | $1,813 |
| EBITDA | -$36,662 | -$32,760 | -$33,380 | -$42,366 |
| % Margin | -313.6% | -335.6% | -279.2% | -977.3% |